台股 » 個股 » 華上 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

華上

(6289)
  • 股價
    1.35
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    0
  • 產業
    上市 發光二極體(LED)▼0.34%
  • 27人加入追蹤

    立即追蹤

  • 本地時間:14:35

     
華上 (6289)籌碼相關-玉山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2022/09/06501.1511.241.134928517.14%
2022/09/0100.00300.810.94-30206-14.56%
2022/08/31200.7214.50.750.865.51603.42%
2022/08/1711.9400.001.941711.41%
2022/08/0400.0002.592.530520.00%
2022/08/0200.0002.642.700510.00%
2022/07/1500.0002.312.400510.00%
2022/07/07102.6600.002.61105019.94%
2022/06/0702.9500.003.050620.00%
2022/03/240.43.3400.003.400.42110.19%
2022/03/2303.3400.003.4002130.00%
2022/03/1663.2000.003.2262132.81%
2022/03/1103.1400.003.3002180.00%
2022/03/1000.00223.383.40-22219-10.02%
2022/03/0800.0093.293.29-9216-4.16%
2022/02/2502.8800.003.0502020.00%
2022/02/22103.0000.003.00102034.92%
2022/01/1023.69104.053.85-8147-5.41%
2021/10/2700.00282.602.64-2838-72.32%
2021/10/2600.00162.602.60-1638-41.27%
2021/10/2200.00142.702.69-1441-33.99%
2021/10/2100.00622.702.70-6242-144.52%
2021/09/1792.8072.802.802712.79%
2021/09/0700.0022.772.80-272-2.75%
2021/08/2422.9000.002.902732.71%
2021/07/28203.2000.003.20207128.04%
2021/07/0800.0063.703.39-695-6.28%
2021/05/0400.00103.313.25-10102-9.77%
2021/05/0300.0063.573.57-6101-5.89%
2021/04/2753.6500.003.6551024.89%
2021/04/2003.4500.003.480940.00%
2021/04/1513.4700.003.471941.03%
2021/03/2303.3000.003.300880.00%
2021/03/1602.9500.002.900810.00%
2021/03/1000.0032.912.91-383-3.58%
2021/03/0503.0400.003.020840.00%
2021/03/040.42.9200.002.900.4840.48%
2021/03/0302.9000.002.890860.00%
2021/03/0203.0000.002.940850.00%
2021/02/2300.0083.153.05-886-9.30%
2021/02/1900.0023.053.05-288-2.27%
2021/02/0500.0013.063.06-188-1.13%
2021/01/25203.5000.003.40209421.18%
2021/01/0453.4000.003.3651184.23%
2020/12/1623.0900.003.0522230.89%
2020/12/1532.9300.002.9632351.27%
2020/12/1033.0400.003.3132911.03%
2020/11/2400.0023.593.59-2344-0.58%
2020/11/2013.6600.003.6713470.29%
2020/11/0900.0013.863.81-1352-0.28%
2020/11/0613.7400.003.7513520.28%
2020/11/0423.4200.003.5123470.58%
2020/10/2823.9100.003.8123450.58%
2020/10/2600.0023.443.60-2345-0.58%
2020/10/2100.0004.084.070337-0.01%
2020/10/1600.0085.324.54-8342-2.34%
2020/10/1200.0034.434.16-3340-0.88%
2020/09/3000.00124.455.14-12331-3.62%
2020/09/2800.0096.335.19-9310-2.90%
2020/09/2427.7200.006.4022910.69%
2020/09/2300.000.57.117.11-0.5272-0.17%
2020/09/21135.8900.005.89132455.30%
2020/09/1784.8800.004.8882163.70%
2020/09/1574.0400.004.0471883.72%
2020/09/1013.7100.003.7111340.74%
2020/09/0700.00222.802.80-22108-20.34%
2020/09/0452.5000.002.5551054.74%
2020/06/2300.000.61.801.89-0.628-2.12%
2020/03/1102.0700.002.0702610.00%
2020/03/1000.000.12.302.30-0.1274-0.05%
2020/01/0600.0060.840.84-6256-2.34%
2019/12/25200.8500.000.85202577.77%
2019/11/22320.8700.000.823214522.06%
2019/10/29200.6200.000.632010918.24%
2019/10/23320.6100.000.613210629.93%
2019/10/21150.5800.000.591510713.99%
2019/10/1890.5600.000.5691078.34%
2019/06/2100.0000.670.6602030.00%
2019/06/1340.6500.000.6542091.91%
2019/05/3120.6400.000.6522110.95%
2019/05/2400.005.10.660.64-5.1220-2.32%
2019/05/0200.000.10.750.80-0.1225-0.05%
2019/04/1800.8500.000.8402290.00%
2019/04/1500.8300.000.8702280.00%
2019/01/2500.0051.301.29-5106-4.70%
2019/01/2401.3400.001.2801080.00%
2019/01/2351.2800.001.3451044.80%
2018/11/1300.0001.251.2601340.00%
2018/11/1200.0001.241.2501330.00%
2018/10/0300.00141.451.40-14218-6.41%
2018/10/0200.00561.471.45-56217-25.72%
2018/08/2200.0041.611.70-4184-2.16%
2018/07/3141.9900.001.9941902.10%
2018/07/2611.9500.001.6111630.61%
2018/07/1651.5100.001.5151044.77%
2018/06/2641.7200.001.7241233.23%
2018/04/2631.9600.001.9131122.66%
2018/04/2021.9800.001.9821141.74%
2018/04/1721.9900.001.9321161.72%
2018/04/0321.9700.001.9521091.83%
2018/03/2722.0800.002.132972.04%
2018/03/2122.0700.002.072972.05%
2018/03/0600.0042.202.19-4117-3.41%
2018/02/2600.0002.242.2801260.00%
2018/02/2200.0002.022.1601270.00%
2018/02/0100.000.52.172.19-0.5135-0.37%
乳癌新藥剋必達上市 華上生醫IPO時程加速Anue鉅亨-2023/09/12
〈華上生醫展望〉乳癌新成分新藥拓展新適應症 肝癌試驗拚年底完成Anue鉅亨-2023/09/08
華上 相關文章